Morrow & Co

Morrow Sodali is a leading global strategic advisory firm that provides corporate boards and executives with advice and services relating to corporate governance, shareholder and bondholder communication and engagement, capital markets intelligence, proxy solicitation, and shareholder activism. While not a biotechnology or pharmaceutical company itself, the firm is a critical player in the life sciences sector, frequently advising biotech and healthcare companies during mergers, acquisitions, and high-stakes proxy contests. The company was formed through the 2016 merger of Morrow & Co. and Sodali, combining decades of experience in proxy solicitation and corporate governance. Morrow Sodali serves over 1,000 corporate clients in more than 80 countries, helping them navigate complex regulatory environments and investor relations.